http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BG-60423-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a157f5faa443ba5bb3367371f1e2a6c7
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18
filingDate 1993-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46fc95a33a1ccbdfa7e0fc56ffc368a8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_352364a37e89f437ab7ef410a0e77e07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e115a0e893a0fdc50bd5f89283daa561
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15975d167c9286919027dc2252d93ee7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f7defb2016d0184bffed02e56acb81a0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_316fbb91787e2863c9776e61397173ea
publicationDate 1995-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BG-60423-B2
titleOfInvention COMPOSITION FOR TREATMENT OF schizophrenia
abstract The pharmaceutical composition comprises the additional acid salt of (N) -N - [- phenyl-isopropyl] -n-methyl-1-propynylamine (selegiline) in a therapeutically effective amount and, optionally, one or more neuroleptics and pharmaceutically acceptable carriers and other excipients.
priorityDate 1988-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25058197
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507096
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2726
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507434
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID26757
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3559
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID432018961
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154132512
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412224541
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16362
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507566
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12083792
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393661
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553097
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449843708
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5452
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535077

Total number of triples: 38.